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Abstract
Background: The aim of this study is to investigate the role of intraoperative MR imaging in temporal lobe low-
grade glioma (LGG) surgery and to report the surgical outcome in our series with regard to seizures, neurological
defects, and quality of life.
Methods: Patients with temporal lobe contrast-nonenhancing gliomas who presented with seizures in the course
of their disease were enrolled in our prospective study. We non-randomly assigned patients to undergo
intraoperative magnetic resonance imaging (iMRI)-guided surgery or conventional surgery. Extent of resection (EOR)
and surgical outcomes were compared between the two groups.
Results: Forty-one patients were allocated in the iMRI group, and 14 were in the conventional group. Comparable
EOR was achieved for the two groups (p = 0.634) although preoperative tumor volumes were significantly larger for
the iMRI group. Seizure outcome tended to be better for the iMRI group (Engel class I achieved for 89.7 % (35/39)
vs 75 % (9/12)) although this difference was not statistically different. Newly developed neurological deficits were
observed in four patients (10.3 %) and two patients (16.7 %), respectively (p = 0.928). Free of seizures and neurological
morbidity led to a return-to-work or return-to-school rate of 84.6 % (33/39) vs 75 % (9/12), respectively (p = 0.741).
Conclusions: Our study provided evidence that iMRI was a safe and useful tool in temporal lobe LGG surgery. Optimal
extent of resection contributed to favorable seizure outcome in our series with low morbidity rate, which led to a high
return-to-work rate.
Keywords: Low-grade glioma, Lesional temporal lobe epilepsy, Intraoperative magnetic resonance imaging,
Neuronavigation, Seizure outcome, Return to work
Background
Seizures are the most frequent and often the only mani-
festation in patients with brain tumors of glial origin,
and medical treatment appears to be less effective for
seizure control because of incomplete understanding of
underlying pathophysiological mechanisms. Particularly,
patients with slow-growing low-grade tumors (low-grade
gliomas (LGGs) and glioneuronal tumors) in cortical
areas of the temporal lobe are more frequently
associated with seizures than high-grade tumors [1–3].
Since patients harboring low-grade tumors tend to live
several years after diagnosis [4, 5], the impact of epilepsy
on disease burden is high. Thus, epilepsy control is one
crucial factor to improve patients’ quality of life, to free
them from disease burden, and to help retain their func-
tional independence and social participation.
It is generally believed that successful surgical resec-
tion of these tumors has a significant effect not only on
the rate of overall survival (OS) and tumor progression
[6–8] but also on seizure outcome. Extent of resection
(EOR) has been suggested to be a strong predictor of
postoperative seizure freedom [2, 9, 10]. However, LGGs
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are infiltrating tumors that do not have distinct borders,
which cannot be easily differentiated from periphral nor-
mal brain tissue with the naked eye. Intraoperative MR
imaging (iMRI) provides information about EOR and al-
lows update of immediate data sets for neuronavigation
to compensate for anatomic changes that occur as a re-
sult of surgical retraction, gravity, and loss of cerebro-
spinal fluid [11, 12]. Combined with neuronavigation
with tractography and functional data, information
about the white matter tracts and eloquent areas and
their relationships with tumors can also be obtained pre-
operatively for evaluation and surgical design and up-
dated during surgery. These intraoperative imaging
techniques have been developed to maximize EOR while
minimized postoperative neurological deficits [13–16],
however, still need to be further tempered by surgical
judgement.
Few studies have demonstrated the effects of iMRI on
surgery of temporal lobe lesional epilepsy patients [17].
In this prospective study, we sought to investigate the
value of high-field iMRI combined with integrated neu-
ronavigation in temporal lobe LGGs resections for seiz-
ure outcome, postoperative morbidity, and rate of return
to normal life and compared these findings with those of
a control cohort without iMRI guidance. Initial, intraop-
erative, and immediate postoperative tumor volumes
were measured quantitatively.
Methods
Study design and patients
Patients with suspected temporal lobe LGG showing
no contrast enhancement on T1-weighted MRI who
presented with seizures were eligible. After giving
their informed consent, these cases were discussed
in the morning meeting in our department, and then
the patients were allocated by the chief resident to
undergo either iMRI-guided or conventional microneuro-
surgical tumor resection (include all standard neurosurgi-
cal instruments and neuronavigation system) according to
the risk and the difficulty of the operation. Only patients
with histopathological examination confirmed temporal
lobe grade II tumors (except gemistocytic astrocytoma)
were enrolled. Functional MRI and fiber tracking were
performed for both groups of patients to localize motor
and speech areas and to reconstruct white matter tracts if
the lesion was in the vicinity of these eloquent regions.
Postoperative treatment was done according to clinical
guidelines and dependent on preferences of the patient.
Follow-up evaluation including neurological examination
and MRI were obtained at regular intervals.
Ethics statement
The local Ethic Committee of Chinese PLA General
Hospital approved intraoperative MRI, and signed informed
consent was provided by all patients or family members.
We had obtained consent to publish from the participants
to report their data in any form.
MRI and data processing
Both conventional MRI and diffusion tensor imaging
(DTI) were performed on a 1.5-T scanner (Siemens
Espree, Erlangen, Germany). Our imaging protocol
started with a T1-weighted 3D magnetization-prepared
rapid-acquisition gradient-echo (MPRAGE) sequence
(echo time (TE) 3.02 ms, repetition time (TR) 1650 ms,
matrix size of 256 × 256, field of view (FOV) 250 mm,
slice thickness 1 mm) and followed by several sequences
applied in the transverse plane, which are T2-weighted
sequence (TE 93 ms, TR 5500 ms, matrix size of 512 ×
512, FOV 230 mm, slice thickness 3 mm); T2 fluid-
attenuated inversion recovery sequence (FLAIR; TE
84 ms, TR 9000 ms, matrix size of 256 × 256, FOV
230 mm, slice thickness 3 mm); and DTI echo planar
(TE 147 ms, TR 9400 ms, matrix size of 128 × 128, FOV
251 mm, slice thickness 3 mm, bandwidth 1502 Hz per
pixel, diffusion-encoding gradients in 12 directions using
b values of 0 and 1000 s/mm2 and voxel size 1.9 × 1.9 ×
3 mm). We used 40 slices, no intersection gap, 40 con-
tinuous free interval collection slices, and five time repe-
titions. The same scanning protocol was used for both
preoperative and intraoperative MRI.
Fiber tracking
For reconstruction and visualization of the fiber tracts,
we used the “fiber tracking” module of the navigation
planning software iPlan 2.6 (BrainLab, Feldkirchen,
Germany). Before tractography could be started, scans
were transferred to a navigation planning workstation in
DICOM format, and format conversion of the data and
fusion of different sets of images were needed. The frac-
tional anisotropy (FA) threshold was adjusted to 0.15
and the minimum fiber length to 40 mm before fiber
tracking was initiated. Tract seeding was performed by
defining a rectangular region of interest (ROI) in the co-
registered standard T1 anatomical datasets and the
color-encoded fractional anisotropy map. For recon-
struction of the optic radiation, one region of interest
(ROI) was placed on the lateral geniculate body identi-
fied by selecting the axial slice at the level of the transi-
tion from the posterior limb of the internal capsule to
the cerebral peduncle on the resection side and a second
ROI was placed at the level of the lower lip (anterior
bundle) or middle and upper lip (central and posterior
bundle) of the visual occipital cortex (calcarine cortex)
on the same side. The arcuate fasciculus tractography
was performed using approaches with two ROI, as re-
ported by Catani et al [18]. For tractography of the pyr-
amidal tract, we used a two-ROI approach described by
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Nimsky and colleagues [19, 20]. After selecting the
appropriate fiber bundle, erasing false-positive tracts,
a 3D object was generated automatically by wrapping
neighboring fibers with a 5-mm hull. The closing
lines around all fibers from all slices together resulted
in the 3D object.
BOLD imaging
For the determination of eloquent cortex, we imple-
mented the “blood oxygenation level dependent (BOLD)
mapping” module. Preoperatively, patients had to per-
form specific tasks including number-counting task and
picture-naming task for language-eloquent cortex
localization. Broca’s area was activated in the posterior
section of the inferior frontal gyrus of the dominant
hemisphere and Wernicke’s area in the posterior section
of the superior temporal gyrus. Repeated hand and foot
movement task was used activate the hand and foot cor-
tex in the pre-central gyrus.
We used the object creation module of the iPlan 2.6
for tumor segmentation. Tumor volume was determined
based on hyperintense region on T2 FLAIR because the
majority of low-grade gliomas have optimal visibility in
this sequence and peritumoral edema could be distin-
guished from the lesion. Segmentation of the tumor was
performed on a slice-by-slice basis in anatomic data.
After all the slices containing the lesion were outlined, a
3D object was formed.
Microscope-based neuronavigation
Preoperative 3D T1-weighted sequence was used for
intraoperative anatomic neuronavigation. Optic radi-
ation, cortical speech areas, and other functional
data, if needed according to tumor location and
tumor volume, were integrated into the anatomical
imaging data. After accurate registration, the neuro-
navigation microscope (Pentero, Carl Zeiss, Oberko-
chen, Germany) was connected. The functional data
were overlaid in the neurosurgeon’s microscope
viewing field; thus, an appropriate incision could be
planned accordingly. When the surgeon had the im-
pression of having a complete resection or further
removal of the lesion might endanger eloquent areas
or functional white matter tracts, an intraoperative
MRI was performed. If residual tumor which could
be further removed was revealed, the intraoperative
MRI and DTI tractography data were used to update
the navigation information, in a way compensating
for intraoperative brain shift caused by tumor resec-
tion, brain swelling, and cerebrospinal fluid outflow-
ing. The initial registration file was restored so that
no repeated image registration procedure is needed.
Imaging would be repeated prior to closure of the
craniotomy to confirm adequate resection of any le-
sion and to exclude any immediate complications
such as hemorrhage.
Primary endpoint was the extent of resection. To
assess the extent of resection, pre- (with contrast
agent within 7 days), intra-, and early postoperative
1.5T high-field MR images were collected to perform
volumetric analyses. For the iMRI group, final extent
of resection (EOR) was calculated based on the last
intraoperative scan before closure. For the conven-
tional group, postoperative MRI was performed within
3 days after surgery to assess the EOR. MRI scan
were performed within 7 days after surgery to rule
out postoperative complications such as intracranial
hematoma and hydrocephalus for all patients. Volu-
metric analyses of the tumors and tumor residuals
were undertaken by an independent and masked neu-
roradiologist to establish the EOR, using the editor
module of 3D slicer 4.3.1 (Fig. 1). Image area of sig-
nal abnormality on T2 FLAIR sequences was seg-
mented manually across all sections. The duration of
surgery were also compared.
Secondary endpoints were neurological deficits im-
mediately as well as 3 months and 6 months after
surgery, and epilepsy outcome according to the modi-
fied Engel classification system was at 1 year [21]. A favor-
able seizure outcome was defined as Engel class IA–D
(seizure-free or rare consciousness-sparing nondisabling
seizures), whereas constant consciousness-imparing sei-
zures were labeled as Engel classes II–IV. Postoperative
neurological deficits were graded as mild (upper visual field
homonymous quadrantanopia, slight aphasia, or latent
mono-paresis) or severe (hemiparesis, hemianopia, or apha-
sia ). Deficit with no clinical improvement at the 6-month
follow-up examination were considered permanent. Pa-
tients’ recent neurological and seizure outcome were gained
from the follow-up examinations in our department and
via telephone interviews. Return to work was obtained at
1 year after surgery.
Statistics
Statistical analyses were performed with the software
Statistical Package for the Social Sciences (version
20.0; SPSS, Inc, Chicago, Illinois). We compared bi-
nomial dichotomized data with Fisher’s exact test or
χ2 test, when appropriate. Mean and median values
between two groups were compared using Student’s
t test or Wilcoxon-Mann-Whitney U test, when ap-
propriate. For the iMRI cohort, correlation between
potential factors and epilepsy outcome (Engel class I
vs Engel classes II–IV) was analyzed using the
Spearman’s rank correlation test. P values of less
than 0.05 were considered statistically significant.
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Results
Study population
We enrolled 59 epilepsy patients who were operated on
in our department between March 2009 and September
2013. Forty-six patients underwent surgery in the iMRI
suite, but five patients were excluded from the study.
Postoperative histopathological examination revealed
three of theses patients had anaplastic astrocytoma; one
patient had parenchyma inflammation. One patient with
gemistocytic histology was excluded to create a more
uniform study population. Thirteen patients underwent
conventional surgery. Thus, data from 54 temporal lobe
World Health Organization (WHO) grade II glioma pa-
tients with preoperative seizures could be analyzed
(Table 1). In our series, 59.3 % of patients were male,
and complex partial seizure was the predominant type.
Before surgery, three patients in the iMRI cohorts were
taking antiepileptic medications and one of them experi-
enced intractable seizures. None were taking AEDs for
the conventional cohorts. Median preoperative tumor
volumes differed significantly between groups (77.0 cm3
(range 5.0–174.0) for the iMRI group and 29.5 cm3
(range 10.0–172.9) for the control group, p = 0.011;
Fig. 2). Larger tumor was reflected as tumor infiltration
beyond temporal lobe, with 34 patients (82.9 %)
infiltrating the insular cortex in the iMRI cohorts vs 4
patients (30.8 %) in the other cohorts (p = 0.001). Com-
parison showed significant difference with respect to
sub-location: 37 (90.2 %) patients in the iMRI group and
8 patients (61.5 %) for the other group showed mesial
structure involvement (p = 0.046). There were no signifi-
cant differences with regard to all other presurgical fac-
tors between the two groups. Two patients in the iMRI
group and one in the other were lost to follow-up.
Volumetric analysis
In the iMRI group, surgery was terminated in 23 pa-
tients (56 %) after first intraoperative scan. Gross total
resection (GTR) was accomplished in 7 of these patients
(30 %). The other 16 patients (70 %) underwent no fur-
ther resection owing to tumor infiltration of eloquent
cortex or fiber bundles. The median preoperative
and residual tumor volumes were 77.6 cm3 (range
4.9–174.0 cm3) and 7.9 cm3 (range 0.0–60.7 cm3),
respectively. The median EOR for all 23 patients was
88.6 % (range 65.1-100 %). In 18 patients (44 %)
who underwent further resection of residual tumor
after first iMRI scan, GTR was achieved after add-
itional tumor removal in 6 of the 18 patients (33 %).
The median preoperative, residual tumor volumes
Fig. 1 Volumetric analysis. Axial MR images obtained in a patient with a right temporal lesion infiltrating the mesial temporal lobe structures. The
lesion showed an irregular shape with no enhancement on the postcontrast T1-weighted images, which was revealed an oligoastrocytoma by
histopathological findings (a). The tumor was more visible on T2 FLAIR and was segmented manually slice by slice using the “paint effect” in the
editor module of 3D slicer (b). Using the “make model effect,” a 3D object was built (c). The tumor volume automatically computed was 42.6 cm3
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after first iMRI and final iMRI were 68.5 cm3 (range
14.8–163.3 cm3), 17.5 cm3 (range 2.6–69.9 cm3), and
3.1 cm3 (range 0.0–43.6 cm3). The median percent-
age of tumor resection were increased from 71.1 %
(range 53.7–95.5 %) after the first scan to 94.4 %
(range 73.3–100 %) determined from the last iMRI
(p < 0.001). In these patients, second iMRI scan
revealed residual tumor resectable in two patients,
so a third scan were performed before finishing
surgery.
When all 41 patients were evaluated, the median
EOR determined from the final iMRI was 92.5 %
(range 65.1–100 %). As a result, the total number of
patients undergoing GTR in the iMRI group was 13
Table 1 Patients’ demographics
Intraoperative MRI group (n = 41) Conventional treatment group (n = 13)
Sex (male) 24 (58.5 %) 8 (61.5 %)
Mean age (range) 36.8 (16–66) 39.4 (11–50)
Site of resection (left) 15 (36.6 %) 4 (30.8 %)
Tumor infiltration
Temporal lobe only 5 (12.2 %) 9 (69.2 %)
Insula 34 (83.0 %) 4 (30.8 %)
Frontal 24 (58.5 %) 4(30.8 %)
Sub-location
Mesial only 23 (56.1 %) 5 (38.5 %)
Lateral only 4 (9.8 %) 5 (38.5 %)






Complex partial 22 (53.7 %) 8 (61.5 %)
Generalized tonic-clonic 20 (48.8 %) 6 (46.2 %)
Simple partial 5 (12.2 %) –
Absence 3 (7.3 %) –
Seizure duration in months (range) 3 (0.25–108) 4.5 (0.25–84)
Median tumor volume in cm3 (range) 77.0 (5.0–174.0) 29.5 (10.0–172.9)
Median follow-up in months 32.5 (9–59) 33.3 (10–64)
Fig. 2 Comparison of tumor volumes between groups. a Preoperative tumor volumes were significantly larger for the iMRI group than the
conventional group (p = 0.013). b There were no significant differences for the two groups in terms of residual tumor volumes (p = 0.736)
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(32 %); in 6 of them (46 %), iMRI contributed directly
to this achievement.
In the conventional group, the median residual tumor
volume was 3.4 cm3 (range 0.0–39.1 cm3), and median
EOR was 90.7 % (range 68.7–100 %) in which GTR was
achieved in 2 patients (15.4 %). No significant difference
was found between the two treatment groups with re-
gard to residual tumor volume (p = 0.736; Fig. 2) and
EOR (p = 0.634).
Surgery duration
Duration of surgery, measured from skin incision to
wound closure, was significantly longer in the iMRI
group (median 540 min (range 300–840)) than it was in
the conventional group (median 300 min (range 240–
720)), due to further removal of residual tumor and
preparing and scanning time needed in the iMRI
group (p < 0.001; Fig. 3). Only one patient in the con-
ventional group underwent surgery over 7 h, owing to
hemostasia difficulty.
Postoperative course
At the most recent follow-up, 35 of the 39 patients
(89.7 %) in the iMRI group were stable and 4 (10.2 %)
had progressed (including 2 deaths), compared with 9 of
the 12 patients (75 %) who were stable in the other
group and 3 (25 %) who had progressed and died (p =
0.413). Postoperative aggravated or new neurological
deficits were observed in 15 of 51 patients (29.4 %).
Twelve of 39 patients were in the iMRI group in which
8 patients returned to normal at the first follow-up visit,
and 3 of 12 patients were in the conventional group
(Table 2). Permanent deficits developed in 4 patients
(10.3 %) in the iMRI group, compared with 2 patients
(16.7 %) in the conventional group (p = 0.928). Intraop-
erative imaging had led to further tumor resection in 2
of the 4 patients with permanent neurological deficits.
Complications that were directly related to the intraop-
erative MRI scan were not observed, particularly postop-
erative infection. One patient developed intracranial
hemorrhage the day after surgery that required immedi-
ate surgical evacuation.
Seizure outcomes
Seizure outcomes tended to be better for patients in the
iMRI group than for the conventional group, although
this difference was not statistically significant (Engel
class I for 89.7 % (35/39) vs 75 % (9/12), respectively;
p = 0.413; Fig. 4). Good seizure control is reflected as
a good rate of return to work: for the iMRI group, 33
patients (84.6 %) returned to work after surgery for
the iMRI group, in which an Engel class I seizure
outcome were achieved in 32 patients and an Engel
class II in 1 patient, and 9 patients (75.0 %) returned
to work for the conventional group, in which an
Engel class I outcome was found in all of them
(p = 0.741).
Spearman rank correlation analysis revealed that
seizure outcome (Engel class) was related to in-
creased EOR (r = −0.452, p = 0.004) and larger tu-
mors (r = 0.391, p = 0.014). Significant correlation
between seizure outcome and factors with regard to
age and preoperative seizure history were not
observed.
Illustrative case
A 26-year-old female had a complex partial seizure
2 weeks before surgery. Preoperative MRI revealed a
nonenhanced lesion in the left temporal lobe (Fig. 5a–c),
and tractography identified the optic radiation passing
rostral to it and was pushed slightly upward. The mini-
mum distance between the lesion and dorsal bundle of
the optic radiation was >5 mm, while Meyer's loop was
closely involved in the lesion (Fig. 5d–f ). The option be-
tween a more conservative resection (lower risk to visual
field) vs a gross-total resection (certain damage to
Meyer’s loop but greater chance of seizure freedom and
reduced risk of tumor recurrence) was discussed, and
Fig. 3 Comparison of time of surgery between groups. Surgery
durations were significantly longer for the iMRI group. The one
patient with exceptional longer time of surgery in the conventional
group was caused by hemostasia difficulty
Table 2 Postoperative complications
Transient Permanent
iMRI group
Focal motor deficit 8a (20.5 %) 2a (5.1 %)
Aphasia 1 (2.6 %) 1 (2.6 %)
Quadrantanopia 4a (10.3 %) 2a (5.1 %)
Conventional group
Hypoesthesia 1 (8.3 %) 1 (8.3 %)
Oculomotor paralysis 1 (8.3 %) 1 (8.3 %)
Quadrantanopia 1 (8.3 %) 0
aOne patient had both a focal motor deficit and quadrantanopia
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the patient chose the latter. A left inferior temporal ap-
proach was planned, and a suitable cortex incision was
designed according to neuronavigation. First, iMRI de-
tected partial tumor remnants (Fig. 6a and d), and intra-
operative DTI-based dorsal bundle of the OR was
reconstructed (Fig. 6b and e). After updating the neuro-
navigation, further resection of the lesion continued.
Final intraoperative scan showed that the lesion was
completely removed (Fig. 6c and f). The pathological
diagnosis was World Health Organization grade II astro-
cytoma. According to the imaging 1 week after surgery,
dorsal bundle of the OR was intact, while anterior
portion of Meyer’s loop was unable to reconstruct
(Fig. 7a, b, d, e). The patient was seizure free at two and
a half years’ follow-up and had a right superior quadran-
tanopia (Fig. 7c and f).
Discussion
Low-grade gliomas are infiltrative tumors which pro-
gressively invade the brain tissue by migrating along the
subcortical white matter tracts. Contrary to the indolent
characteristics claimed by classical literature, there is a
constant growth pattern of these tumors before and after
surgery in cases of incomplete resection [22]. Tumor
Fig. 4 Engel classification outcome of the two groups of patients
Fig. 5 Preoperative MR imaging. Conventional MRI showed a lesion located in the left temporal lobe involving the mesial temporal structures
with no contrast enhancement (a–c). The reconstructed optic radiation was rostral to the lesion, and Meyer’s loop was closely involved in the
lesion (d, e orange, dorsal bundle; brown, Meyer’s loop). The 3D relationship between the lesion and the optic radiation is shown (f)
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progression will inevitably occur, which will lead to
neurological deficits with a deteriorating of quality of life
and ultimately to death. Since surgery is the first thera-
peutic option to consider in LGG, the impact of surgery
has been studied in numerous literature, supporting the
significant effect of EOR on overall survival (OS) by
delaying anaplastic transformation, even in incomplete
tumor removal [7, 8, 23]. However, LGG tends to have
ill-defined margin which is nearly impossible to distin-
guish from peritumoral normal brain under the micro-
scope with the naked eye, and EOR tend to be
overestimated even by experienced neurosurgeons.
Fig. 6 Intraoperative MR imaging. The same patient as in Fig. 1. The first iMRI scan demonstrated that the partial lesion prior to the cavity
remained (a, d). After infusion of the intraoperative optic radiation tractography and the outlined residual tumor, the neuronavigation was
updated (b, e). Final iMRI scan revealed that the tumor remnants had been removed (c, f)
Fig. 7 Examination 1 week after surgery. The same patient as in Figs. 1 and 2. Postoperative MRI showed that the dorsal bundle of the optic
radiation was well preserved, while anterior tip of Meyer’s loop was damaged (a, b, d, e; brown, dorsal bundle; yellow, Meyer’s loop). The patient
developed right superior quadrantanopia of both eyes (c, f)
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Intraoperative MRI is today an increasingly proved
useful tool for operations of many brain lesions, espe-
cially for small deep seated tumors. This technique pro-
vides nearly real-time images, which allows detection of
residual tumors and immediate intraoperative complica-
tions. Furthermore, it enables intraoperative update of
registration compensating for brain shift caused by out-
flow of cerebrospinal fluid, deformation from retraction
and effects of gravity [12].
Extent of resection
For discussion of impact of iMRI on glioma surgery, the
resection control was the most relevant feature which
has been validated by different studies [13, 14, 24, 25].
And the advantage provided by iMRI for further reduc-
tion of tumor volume was obvious. One prospective
volumetric analysis enrolled both low and high-grade
glioma cases and reported that EOR of contrast-
nonenhancing tumors benefit more from iMRI scan than
enhancing tumors, possibly due to diffuse signal abnor-
mality of nonenhancing gliomas on T2-weighted images.
The median percentage of tumor resected in patients
with nonenhancing gliomas improved from 63 to 80 %,
although this was not statistically significantly due to
small sample size [24]. In our series, we uniformly en-
rolled WHO grade II gliomas focusing on temporal lobe
location. As a consequence of iMRI imaging, we identi-
fied 44 % of patients with residual tumors intraopera-
tively and continued surgery using the updated
neuronavigation data, and EOR of these patients in-
creased significantly from 71.1 to 94.4 %. Final iMRI
scans documented gross-total resection rate of 31.7 %, in
which 14.6 % of improvement benefited directly from
iMRI. Compared to another study investigating impact
of iMRI on lesional temporal lobe epilepsy surgery, this
seems low [17]. However, WHO grade I tumors (GGs
and DNTs) made up the majority of their cases, which
might be less infiltrative than LGG and tumor borders
might be clearer. Further, they adopted qualitative
categorization of EOR instead of volumetric manual seg-
mentation of the tumor. It is likely that tumor volume
were limited in their series; thus, tumors were less in-
volved with eloquent areas. Of note, inter-observer vari-
ances exist even for the quantitative approach, which
theoretically has the advantage of higher precision [26].
Stratified analysis with regard to pathological diagnosis
and tumor location using validated criteria to assess
EOR are needed for comparisons of results between
studies in the future.
A randomized, controlled trial was conducted aiming
to assess the efficacy of iMRI guidance on extent of re-
section in patients with glioma [25]. They randomly allo-
cated patients with contrast enhancing gliomas to
undergo tumor resection either with iMRI guidance or
with conventional microneurosurgical instruments and
techniques. Their data showed significantly better extent
of resection and decreased residual tumor volume in the
iMRI group than in the control group, and this benefit
was associated with an extended progression-free sur-
vival (PFS). However, we were unable to conduct a ran-
domized trial due to cost-effective considerations. We
would only propose an iMRI-guided surgery if preopera-
tive imaging data had presented a large tumor with dif-
fuse component in close relationship with functional
subcortical white matter tracts because an iMRI-guided
surgery was quite costly. This resulted in the larger
tumor volumes in the iMRI group and highly uneven
number of observations between the two groups. How-
ever, although selection bias set up a challenge for the
resection in the iMRI group, comparable results were
achieved with regard to final residual tumor volume and
EOR, which could reflect indirectly the beneficial effect
of guidance with iMRI for complete resection of LGGs
compared with conventional microsurgery. Our study
was not powered or designed to show whether this
benefit corresponded to an increase in PFS and OS.
Functional neuronavigation
As has been reported, BOLD MRI and DTI-based fiber
tracking were noninvasive tools to localize eloquent gray
matter and white matter tracts which can be integrated
into a neuronavigation system. Eloquent cortex includ-
ing the primary motor regions and Broca and Wernicke
areas and functional subcortical connectivity including
pyramidal, language, and visual tracts were successfully
created and implemented in all patients in the iMRI co-
horts as needed to reduce the potential risk of damage
to these structures [12, 16, 20, 27, 28]. When the process
of fiber tracking was done, we tended to add a 5-mm
hull around the object. During surgery, the surgeon
would be reminded that the manipulation was getting
closer to the object if the contouring line turned from
dotted to solid under the microscope. Sometimes, we
had to leave some residual tumor in the brain when try-
ing to dissect the tumor boundaries from the tracts in
cases of relatively severe compression. When the sur-
geon had the impression of a satisfactory resection or
further resection might pose a threat to functional re-
gion, an iMRI scan was performed to evaluate the EOR
and update information acquired for the neuronaviga-
tion. In terms of neurological outcome, our results were
more favorable than previous literature [23, 29, 30], with
permanent mono-paresis occurred in two patients,
upper visual field defects in two patients, mild aphasia
in one patient, and complications occurred in two pa-
tients in whom iMRI led to continued resection of
tumor tissue. This underlined the fact that the applica-
tion of multimodal navigation combined iMRI was a safe
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and advantageous technique. Reviewing preoperative sur-
gical planning of integrated anatomical and functional
data of the two mono-paresis patients, we found rather se-
vere tumor compression of the posterior limb of internal
capsule, and the pyramidal tract reconstructed presented
an obvious inward curve. Of note, our data showed that
surgery in the iMRI operation room consumed signifi-
cantly more time than it did in other rooms, not due to
only continued resection but also preparation and scan-
ning time. Fortunately, this did not resulted in wound in-
fection in any patient. For the conventional group, two
patients developed permanent postoperative defects. Pre-
operative MRI revealed a mesial temporal lobe lesion in-
vading the interpeduncular fossa and prepontile cistern
for the patient who had postoperative oculomotor
paralysis.
Tumor-related epilepsy
Given the fact that low-grade gliomas are slow progres-
sing tumors which are more frequently associated with
symptomatic focal seizures than high-grade gliomas, epi-
lepsy usually represents the key clinical issue in these pa-
tients. Although surgery is facilitated by advances in
preoperative and intraoperative techniques such as
multimodal integrated neuronavigation, iMRI and elec-
trical cortical and subcortical stimulations to perform a
safe and maximal resection even for eloquently located
LGGs, surgery cannot cure these patients. Good seizure
outcome and increased quality of life in these patients
with many years of survival expectancy should remain a
priority. However, whether observational waiting until
the occurrence of drug-resistant epilepsy or early resec-
tion irrespective of seizure control should be proposed
has long been discussed [31]. From oncologic observa-
tions, convincing evidence has been provided that early
surgery significantly improves PFS and OS [32]. Mean-
while, postoperative seizure outcome correlated with
preoperative seizure history [9], so presumably, a timely
surgery might also prove optimal for seizure control.
Our study reflected a cohort routinely seen in a neuro-
oncology clinic and did not focus only on patients with
intractable epilepsy. Most patients in our study had
sporadic seizures without long-term regular medications.
As a result, duration between seizure onset and surgery
was significantly shorter compared with other studies,
which was considered to be one of the factors contribute
to our exceptional seizure outcome [17, 30]. However,
we did not observe an influence of seizure history on
seizure outcome as others did [2, 9, 33], possibly attrib-
utable to the small sample size and fewer poor outcomes
in our population.
Tumor-related epilepsy had unknown mechanisms,
and several hypotheses for epileptogenesis including
blood-brain barrier disruption, metabolic changes due to
vascular disturbance, and functional connectivity alter-
ation had been proposed [34]. Since these changes might
take place not only within the tumor but also in peritu-
moral area or even distant from the tumor, the epilepto-
genic zone was not always resected with oncological
surgery. Thus, conventional oncological surgery might
not be sufficient to achieve a desirable seizure outcome,
and consideration should be given to a more extended
resection, especially in patients with tumors in or
around temporal lobe because mesial temporal struc-
tures might become an independent seizure generator
and may be responsible for postoperative persistent seiz-
ure activity [35]. In one meta-analysis, Englot et al. re-
ported additional benefit with regard to seizure outcome
for tailored resection including hippocampectomy plus
corticectomy over gross-total lesionectomy alone [10].
However, we noticed in the literature that the associ-
ation between tumor and hippocampal sclerosis (HS) is
rare, with HS coupled with a tumor occurred in only 7–
8 % of cases [36, 37]. Further, some studies reported
similar seizure outcome between groups regarding the
resection of hippocampus and amygdala [30, 37]. When
trying to explain the similar results achieved in temporal
lobe epilepsy surgery using different approaches with
different extent of resection of temporal lobe mesial
structures, Abosch et al. hypothesized that it would be
enough to sever or interrupt a large enough proportion
of the network between these structures, so that a seiz-
ure is unable to be built up or sustained [38]. In
addition, the insular cortex was associated with seizure
spread [3]. This is probably why satisfactory seizure out-
come could be achieved by some studies performing
lesionectomy alone or even subtotal tumor resection
[39, 40] and why mesial temporal location prognosti-
cated favorable seizure outcome in tumoral epilepsy pa-
tients [9]. In our series, excluding patients that were lost
to follow-up, 82.1 % of patients in the iMRI group had
tumor invasion of the insular cortex and 89.7 % of pa-
tients had tumor involvement of the mesial structures of
temporal lobe, which was significantly higher than that
in the conventional group (insular cortex involvement:
25.0 %; mesial structure involvement: 58.3 %). Reducing
an epileptogenic mass involving these regions was more
likely to include excision of the mesial temporal struc-
tures and the insular cortex and might possibly resulting
in disconnection of critical seizure propagation path-
ways. This was considered to be another factor contrib-
uting to our favorable seizure outcome.
Return to work
Return to work could be used as a surrogate parameter
for patients’ good performance status as well as im-
proved quality of life. It required not only a high degree
of independence but also spared cognitive functions.
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Among patients in our iMRI cohort, 84.6 % had
returned to work or school within 1 year after surgery.
This rate of return to work was comparable to a previ-
ous study, which reported 90.3 % of patients returned to
work 6 months after surgery in a cohort with frontal
lobe LGG patients, indicating that return to previous
lifestyle can be achieved for most LGG patients after
surgery [41]. In our iMRI cohort, other problems includ-
ing neurological defects and tumor progression pre-
vented patients who had an Engel class I seizure
outcome from returning to work in 3 patients. Three pa-
tients had not returned to work in the conventional
group, all due to tumor progression. Thus for the rela-
tively young patients with tumor-related epilepsy pa-
tients, complete seizure freedom without postoperative
adverse events was the ultimate goal of each resective
procedure.
Limitation
One major limitation of the study was that it was not
done in a double-blinded, randomized manner, which
allowed the existence of selection bias. It also resulted in
the highly uneven numbers of observations between the
groups. However, even the patients with larger tumors
were allocated to undergo surgery in the iMRI operation
room; similar results were observed with regard to EOR,
and although not statistically significant, even better re-
sults for the iMRI group with regard to seizure outcome.
This is done without the compromise of patients’ post-
operative neurological function, indicating the advantage
of iMRI-guided surgery over conventional approach.
Our finding might also be restricted by the fact that our
study was done at only one center, which resulted in
possible admission bias. Still, we believed that our results
were valid and provided additional information for the
most controversial topics in lesional temporal lobe epi-
lepsy surgery.
Conclusions
In conclusion, the best surgical approach to temporal
lobe LGG-related epilepsy is still debated. Timely sur-
gery before the seizure becomes medically intractable is
advisable. More aggressive resection of the infiltrative
temporal lobe WHO grade II tumors which frequently
involving the mesial structures and even the insular cor-
tex may contribute to a satisfactory long-term seizure
outcome. iMRI is a safe and appropriate method to im-
prove the extent of resection of LGGs. The multimodal
intraoperative imaging technique led to a favorable
Engel class I outcome in our study with low morbid-
ity rate. In majority of temporal lobe LGG-related
epilepsy patients, surgery will free them from seizures,
and they will retain their functional independence and
normal state of social life.
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